Altimmune Inc (NASDAQ:ALT) price closed higher on current market day and jumping 13.28% above its previous close.
A look at the daily price movement shows that the last close reads $5.95. Taking into account the 52-week price action we note that the stock hit a 52-week high of $11.16 and 52-week low of $3.55. The stock added 20.57% on its value in the past month.
Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Specifically, 6 analysts have assigned ALT a recommendation rating as follows: 0 rate it as a Hold; 6 advise Buy while 0 analyst(s) assign an Overweight rating. 0 analyst(s) have tagged the Altimmune Inc (ALT) stock as Underweight, with 0 recommending Sell. In general, analysts have rated the stock Buy, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares.
The overview shows that ALT’s price is at present 19.02% off the SMA20 and 29.88% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 70.15, with weekly volatility standing at 5.52%. The indicator jumps to 4.21% when calculated based on the past 30 days. Altimmune Inc (NASDAQ:ALT)’s beta value is holding at 0.58, while the average true range (ATR) indicator is currently reading 0.39. Considering analysts have assigned the stock a price target range of $12-$35 as the low and high respectively, we find the trailing 12-month average consensus price target to be $25. Based on this estimate, we see that current price is roughly -78.04% off the estimated low and -419.29% off the forecast high. Investors will no doubt be excited to see the share price fall to $25, which is the median consensus price, and at that level ALT would be -270.92% from current price.
Current records show that the company has 81.11M in outstanding shares. The insiders’ percentage holdings are 1.04% of outstanding shares while the percentage share held by institutions stands at 47.38%. But the -6.52% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
